Advertisement

Effect of Interferons on the Activation of Murine Peritoneal Macrophages to Inhibit the Growth of Listeria Monocytogenes

  • Alison M. Badger
  • Barbara A. Swift
  • Barbara J. Dalton
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 239)

Abstract

Peritoneal macrophages are activated to become antimicrobial in vivo by infection with intracellular parasites (1,2) or in vitro by lymphokine-containing lymphocyte supernatants (3–7). One component of these mitogen stimulated lymphocyte supernatants, gamma interferon (IFN-γ), has been shown to be responsible for the ability of lymphokine supernatants to activate a variety of macrophage functions, including microbicidal and tumoricidal activity. However, there do appear to be non-interferon components of these supernatants that can render macrophages to become microbicidal (8). Izadkhah et al. (9) first demonstrated that treatment of mice with sera containing IFN-γ was able to increase the survival of mice infected with Salmonella typhimurium. More recent studies with pure and recombinant murine IFN-γ (rMuIFN-γ) have demonstrated that this lymphokine can indeed activate macrophages to inhibit the growth of (or kill) several intracellular parasites. IFN-γ treatment (both in vitro and in vivo) inhibits the intracellular protozoa Toxoplasma gondii (10,11) and Leishmania donovani (12) and the in vivo growth of Listera monocytogenes (13). A recent report indicates that the in vivo production of IFN-γ is required for the clearance of Listeria in infected mice (14). In human studies IFN-γ has been shown to activate peripheral monocytes to kill Toxoplasma gondii (15) and Leishmania donovani in vitro (12, 16) and a recent study describes the enhanced capacity of these cells to kill Listeria (17).

Keywords

Peritoneal Macrophage Gamma Interferon Listeria Monocytogenes Mouse Peritoneal Macrophage Peritoneal Exudate Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    G.B. Mackaness, Cellular resistance to infection. J. Exp. Med. 116: 381–406 (1962).PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    G.B. Mackaness, The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J. Exp. Med. 129: 973–992 (1969).PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    P. Cole, Activation of mouse peritoneal cells to kill Listeria monocytogenes by T-lymphocyte products. Infect. Immun. 12: 36–41 (1975).PubMedCentralPubMedGoogle Scholar
  4. 4.
    F.E. Fowles, I.M. Fajardo, J.L. Leiboritch, and J.R. David, The enhancement of macrophage bacteriostasis by products of activated lymphocytes. J. Exp. Med. 138: 952–964 (1973).PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    R.W. Godfrey, P.G. Horton, and M.S. Wilder, Time course of antilisterial activity by immunologically activated murine peritoneal macrophages. Infect. Immun. 39: 532–539 (1983).PubMedCentralPubMedGoogle Scholar
  6. 6.
    T. Jones, and G.P. Youmans, The in vitro inhibition of growth of intracellular Listeria monocytogenes by lymphocyte products. Cell. Immunol. 9: 353–362 (1973).PubMedCrossRefGoogle Scholar
  7. 7.
    J.L. Krahenbuhl, and J.S. Remington. In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes. Infect. Immun. 4: 337–343 (1971).Google Scholar
  8. 8.
    C.A. Nacy, A.H. Fortier, M.S. Meltzer, N.A. Buchmeier, and R.D. Schreiber, Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-Y and non-interferon lymphokines. J. Immunol. 135: 3505–3511 (1985).PubMedGoogle Scholar
  9. 9.
    Z. Izadkhah, A.D. Mandel, and G. Sonnenfeld, Effect of treatment of mice with sera containing gamma interferon on the course of infection with Salmonella typhimurium strain LT-2. J. Interferon Res. 1: 137–145 (1980).PubMedCrossRefGoogle Scholar
  10. 10.
    R.E. McCabe, B.J. Luft, and J.S. Remington, Effect of murine interferon gamma on murine Toxoplasmosis. J. Infect. Dis. 150: 961–962 (1984).PubMedCrossRefGoogle Scholar
  11. 11.
    H.W. Murray, G.L. Spitalny, and C.F. Nathan, Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-Y. J. Immunol. 134: 1619–1622 (1985).PubMedGoogle Scholar
  12. 12.
    H.W. Murray, B.F. Rubin, and C.D. Rothermel, Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-Y is the activating lymphokine. J. Clin. Invest. 72: 1506–1510 (1983).PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    A.F. Kiderlen, S.H.E. Kaufmann, and M.L. Lohmann-Matthes, Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur. J. Immunol. 14: 904–907 (1984).CrossRefGoogle Scholar
  14. 14.
    N.A. Buchmeier, and R.D. Schreiber, Requirement of endogenous interferon-Y production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. 82. 7404–7408 (1985).PubMedCrossRefGoogle Scholar
  15. 15.
    C. Nathan, H.W. Murray, M.E. Wiebe, and B.F. Rubin, Identification of interferon-Y as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158: 670–689 (1983).PubMedCrossRefGoogle Scholar
  16. 16.
    D.L. Hoover, C.A. Nacy, and M.S. Meltzer Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-Y. Cell. Immunol. 94: 500–511 (1985).PubMedCrossRefGoogle Scholar
  17. 17.
    R. Peck, A one-plate assay for macrophage bactericidal activity. J. Immunol. Methods 82: 131–140 (1985).PubMedCrossRefGoogle Scholar
  18. 18.
    T.P. Koestler, A.M. Badger, D.J. Rieman, R. Greig, and G. Poste, Induction by immunomodulatory agents of a macrophage antigen recognized by monoclonal antibody 158.2 and correlation with macrophage function. Cell. Immunol. 96: 113–125 (1985).PubMedCrossRefGoogle Scholar
  19. 19.
    C.A. Ogburn, K. Berg., and K. Paucker, Purification of mouse interferon by affinity chromatography on anti-interferon globulin sepharose. J. Immunol. 111: 1206–1218 (1973).PubMedGoogle Scholar
  20. 20.
    B. Dalton, and K. Paucker, Preparation and absorption of antiserum against mouse L cell interferon. Methods in Enzymology 79: 582 (1981).PubMedCrossRefGoogle Scholar
  21. 21.
    G.L. Spitalny, and E.A. Havell, Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J. Exp. Med. 159: 1560–1565 (1984).PubMedCrossRefGoogle Scholar
  22. 22.
    A.M. Badger, S.R. Cooperband, and V.J. Merluzzi, The production of proliferation inhibitory factor (PIF) by mouse spleen cells in vitro. J.Immunol. 112: 1435–1443 (1974).Google Scholar
  23. 23.
    L., Harrington-Fowler, P.M. Henson, and M.S. Wilder, Fate of Listeria monocytogenes in resident and activated macrophages. Inf. and Immun. 33: 11–16 (1981).Google Scholar
  24. 24.
    G.L. Spitalny, and R.J. North, Destruction of Listeria monocytogenes in vitro. In: Methods for Studying Mononuclear phagocytes. Ed. Adams, D.O., Edelson, P.J. and Hillel, K. Academic Press. 685–691 (1981).Google Scholar
  25. 25.
    J.J. Mond, F.D. Finkelman, C. Sarma, J. Ohara, and S. Serrate, Recombinant interferon-Y inhibits the B cell proliferative response stimulated by soluble but not by sepharose-bound anti-immunoglobulin antibody. J. Immunol. 135: 2513–2517 (1983).Google Scholar
  26. 26.
    J.L. Pace, S.W. Russell, P.A. LeBlanc and D.M. Murasko, Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing. J. Immunol. 134: 977 (1985).PubMedGoogle Scholar
  27. 27.
    W.K. Roberts, and A. Vasil, Evidence for the identity of murine gamma interferon and macrophage activating factor. J. Interferon Res. 2: 519–532 (1982).PubMedCrossRefGoogle Scholar
  28. 28.
    W.R. Fleischmann, J.A. Georgiades, L.C. Osborne, and H.M. Johnson, Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon. Infect. Immun. 26: 248–256 (1979).PubMedCentralPubMedGoogle Scholar
  29. 29.
    W.R. Fleischmann, Potentiation of the direct anticellular activity of mouse interferons: Mutual synergism and interferon concentration dependence. Cancer Res. 42: 869–875 (1982).PubMedGoogle Scholar
  30. 30.
    D.A. Weigent, M.P. Langford, W.R. Fleischmann, and G.J. Standon, Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon. Infect. Immun. 40: 35–38 (1983).PubMedCentralPubMedGoogle Scholar
  31. 31.
    P.A. Campbell, Are inflammatory phagocytes responsible for resistance to facultative intracellular bacteria Immunol. Today 7 (3): 70–72 (1986).Google Scholar
  32. 32.
    R.C. Bast, Jr., R.P. Cleveland, B.H. Littman, B. Zbar, and H.J. Rapp, Acquired cellular immunity: extracellular killing of Listeria monocytogenes by a product of immunologically activated macrophages. Cell. Immunol. 10: 248–259 (1974).Google Scholar
  33. 33.
    G. Middlebrook, B.J. Salmon, and J.I. Kreisberg, Sterilization of Listeria monocytogenes by guinea pig peritoneal exudate cell cultures. Cell. Immunol. 14: 270–283 (1974).PubMedCrossRefGoogle Scholar
  34. 34.
    K.K. Sethi, M. Teschner, and H. Brandis, In vitro antilisterial activity of soluble product(s) released from Listeria-immune murine peritoneal macrophages. Infect.Immun. 10:960–962. (1974).Google Scholar
  35. 35.
    D. Adam, F. Staber, B.H.,Belohradsky, and W. Marget, Effect of dihydrostreptomycin on phagocytosis of mouse peritoneal macrophages in vitro. Infect. Immun. 5: 537–541 (1972).Google Scholar
  36. 36.
    P. Cole, and J. Brostoff, Intracellular killing of Listeria monocytogenes by activated macrophages (Mackaness system) is due to antibiotic. Nature (London) 256: 515–517 (1975).CrossRefGoogle Scholar
  37. 37.
    H. Rollag, M. Degre, and G. Sonnenfeld, Effects of interferon-a/B and interferon-Y preparations on phagocytosis by mouse peritoneal macrophages. Scand. J. Immunol. 20. 149–155 (1984).PubMedCrossRefGoogle Scholar
  38. 38.
    E.R. Pfefferkorn, Interferon-Y blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Nat. Acad. Sci. 81: 908–912 (1984).PubMedCrossRefGoogle Scholar
  39. 39.
    D. Ottendorfer, D. Bitter-Suermann, and U. Hadding, An in vitro system to study Listericidal capacity of macrophages from separate mice: resident macrophages exhibit different activation patterns. Infect. Immun. 49: 685–691 (1985).PubMedCentralPubMedGoogle Scholar
  40. 40.
    J. Bennedsen, S. J. Riisgaard, M. Rhodes, and S.O. Larsen, In vitro studies on normal stimulated and immunologically activated mouse macrophages III. Intracellular multiplication of Listeria monocytogenes. Acta Pathol. Microbiol. Scand.Sect.C 85: 246–252 (1977).Google Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Alison M. Badger
    • 1
  • Barbara A. Swift
    • 1
  • Barbara J. Dalton
    • 1
  1. 1.Department of Immunology and Anti-Infective TherapySmith Kline and French LaboratoriesSwedelandUSA

Personalised recommendations